Paromomycin
ATC A07AA06 · 6 markets · 16 records
Paromomycin
Forms
GB 6 records · 4 strengths
CN 5 records · 2 strengths
- 250 mgtabletManufacturer: 广州白云山光华制药股份有限公司 ×2__mah__:开封制药(集团)有限公司
- 100 mgtabletManufacturer: 广州白云山光华制药股份有限公司 ×2__mah__:开封制药(集团)有限公司
US 1 records · 1 strengths
- 250 mgcapsuleHumatin
CA 1 records · 1 strengths
- 250 mgcapsuleHumatin
ES 1 records · 1 strengths
- 250 mgcapsuleHumatin
| Strength / form / release | US | GB | CA | CN | ES |
|---|---|---|---|---|---|
| 250 mgRecorded as: 0.25 g tablet | No trade name Gabbroral 250mg tablets | Manufacturer: 广州白云山光华制药股份有限公司 ×2 Manufacturer: 开封制药(集团)有限公司 ×3 | |||
| 250 mg capsule | Humatin | Humatin | Humatin | Humatin | |
| 100 mgRecorded as: 0.1 g tablet | Manufacturer: 广州白云山光华制药股份有限公司 ×2 Manufacturer: 开封制药(集团)有限公司 ×3 | ||||
| 125 mg/5 mL liquid | No trade name Humatin | ||||
| 250 mg topical | No trade name |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.